These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 726085)

  • 1. Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.
    Garcia-Rodriguez JA; Martin-Luengo F
    Tubercle; 1978 Dec; 59(4):277-80. PubMed ID: 726085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.
    Dalovisio JR; Pankey GA
    J Infect Dis; 1978 Mar; 137(3):318-21. PubMed ID: 632627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
    Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Swenson JM; Silcox VA; Good RC
    J Clin Microbiol; 1982 Dec; 16(6):1003-6. PubMed ID: 6298271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
    Wallace RJ; Dalovisio JR; Pankey GA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):611-4. PubMed ID: 526002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds.
    Yew WW; Kwan SY; Ma WK; Lui KS; Aung MK
    Clin Ther; 1989; 11(6):775-85. PubMed ID: 2611821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ; Swenson JM; Silcox VA; Bullen MG
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.
    Stone MS; Wallace RJ; Swenson JM; Thornsberry C; Christensen LA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):486-93. PubMed ID: 6651277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems in diagnosis and therapy of Mycobacterium fortuitum infections.
    Dalovisio JR; Pankey GA
    Am Rev Respir Dis; 1978 Apr; 117(4):625-30. PubMed ID: 646215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly growing members of the genus Mycobacterium affecting dogs and cats.
    Jang SS; Hirsh DC
    J Am Anim Hosp Assoc; 2002; 38(3):217-20. PubMed ID: 12022405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.
    Swenson JM; Thornsberry C; Silcox VA
    Antimicrob Agents Chemother; 1982 Aug; 22(2):186-92. PubMed ID: 6927280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.
    Welch DF; Kelly MT
    Antimicrob Agents Chemother; 1979 Jun; 15(6):754-7. PubMed ID: 475359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
    Carpenter JL; Troxell M; Wallace RJ
    Arch Intern Med; 1984 Oct; 144(10):2063-5. PubMed ID: 6486990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents.
    Sanders WJ; Wolinsky E
    Antimicrob Agents Chemother; 1980 Oct; 18(4):529-31. PubMed ID: 7447416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Mycobacterium fortuitum to antibacterial agents as evaluated by disk diffusion and agar dilution methods.
    Orefici G; Scopetti F
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):402-5. PubMed ID: 6322817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.
    Hoffner SE; Klintz L; Olsson-Liljequist B; Bolmström A
    J Clin Microbiol; 1994 Aug; 32(8):1846-9. PubMed ID: 7989530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.
    Sanders WE; Hartwig C; Schneider N; Cacciatore R; Valdez H
    Tubercle; 1982 Sep; 63(3):201-8. PubMed ID: 6817487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro sensitivity of Mycobacterium avium and Mycobacterium xenopi to erythromycin, roxithromycin and doxycycline].
    Maugein J; Fourche J; Mormede M; Pellegrin JL
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):565-7. PubMed ID: 2797881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.
    Ho YI; Chan CY; Cheng AF
    J Antimicrob Chemother; 1997 Jul; 40(1):27-32. PubMed ID: 9249201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.